The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail

TOPAMAX 200mg Film-coated Tablets

Janssen Sciences Ireland UCPA22612/013/004

Main Information

Trade NameTOPAMAX 200mg Film-coated Tablets
Active SubstancesTopiramate
Dosage FormFilm-coated tablet
Licence HolderJanssen Sciences Ireland UC
Licence NumberPA22612/013/004

Group Information

ATC CodeN03AX Other antiepileptics
N03AX11 topiramate


License statusAuthorised
Licence Issued13/06/1997
Legal statusProduct subject to prescription which may be renewed (B)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusMarketed


Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available
« Back